Tag

Medicines

Affordable drugs Novartis cancer treatment for CHF 370,000?! Public Eye opposes Kymriah patent

3 July 2019

Report Post-Trial Access to Swiss Medicines

2019

Clinical trials Roche and Novartis neglect their ethical responsibility in emerging countries

20 May 2019

Panel discussion No fair pricing without transparency

11 April 2019

News Stop TRIPS-plus measures in trade agreement with Indonesia

6 November 2018

Press Release 33,000 signatures: curb the exorbitant cost of medicines

13 September 2018

Report Protect patients, not patents

2018

Press Release Compulsory licensing in Colombia: Aggressive lobbying by Novartis

12 April 2017

Report Clinical Drug Trials: Conference Report 2016

2016

News Successful conference on clinical drug trials

30 September 2016